Dianthus Therapeutics | MGTA - Pre Tax Profit


Dianthus Therapeutics reported $-40.83M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -11.64M 12.13M Dec/2025
Celltrion KRW 11.84B 1.34B Mar/2026
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 9.63B 1.09B Mar/2026
IQVIA Holdings USD 6.22B 5.68B Mar/2026
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Moderna USD -799M 612M Dec/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organigram Holdings CAD -921K 40.8M Mar/2026
Organon & Co USD 213M 361M Mar/2026
Pharma Mar EUR 1.6M 38.6M Mar/2026
Qiagen NV USD 109.17M 25.56M Dec/2025
Revvity USD 91.56M 35.88M Dec/2025
Sartorius EUR 157.8M 76.1M Mar/2026
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Tilray USD -39.96M 39.19M Sep/2025
Viatris USD -343M 335.1M Dec/2025
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026
Zealand Pharma A/S -406.5M 39.77M Dec/2025
Zz Pientze Pharmaceu CNY 876.07M 352.96M Mar/2026